EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mammalian Target of Rapamycin Inhibitors and Wound Healing Complications in Kidney Transplantation: Old Myths and New Realities

Muhammad Abdul Mabood Khalil iD, Saeed M G Al-Ghamdi iD, Ubaidullah Shaik Dawood iD, Said Sayed Ahmed Khamis iD, Hideki Ishida iD, Vui Heng Chong iD, Jackson Tan iD

Journal of Transplantation · 28.02.2022 · 2022 · 1-28

DOI: 10.1155/2022/6255339 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Transplantation, erschienen am 28.02.2022. Verfasst von Muhammad Abdul Mabood Khalil und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, RIPAS Hospital, Bandar Seri Begawan BA1710, Brunei Darussalam. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mammalian target of rapamycin inhibitors (mTOR-I) lacks nephrotoxicity, has antineoplastic effects, and reduces viral infections in kidney transplant recipients. Earlier studies reported a significant incidence of wound healing complications and lymphocele. This resulted in the uncomfortable willingness of transplant clinicians to use these agents in the immediate posttransplant period. As evidence and experience evolved over time, much useful information became available about the optimal use of these agents. Understandably, mTOR-I effects wound healing through their antiproliferative properties. However, there are a lot of other immunological and nonimmunological factors which can also contribute to wound healing complications. These risk factors include obesity, uremia, increasing age, diabetes, smoking, alcoholism, and protein-energy malnutrition. Except for age, the rest of all these risk factors are modifiable. At the same time, mycophenolic acid derivatives, steroids, and antithymocyte globulin (ATG) have also been implicated in wound healing complications. A lot has been learnt about the optimal dose of mTOR-I and their trough levels, its combinations with other immunosuppressive medications, and patients’ profile, enabling clinicians to use these agents appropriately for maximum benefits. Recent randomized control trials have further increased the confidence of clinicians to use these agents in immediate posttransplant periods.

Autor:innen und Institutionen

  • Department of Nephrology, RIPAS Hospital, Bandar Seri Begawan BA1710, Brunei Darussalam.
  • Department of Medicine Faculty of Medicine, King Abdul Aziz University, Jeddah 21589, Saudi Arabia.
  • Department of Medicine Nephrology, Division Faculty of Medicine, Menoufia University Hospital, Shibin Al Kawm, Egypt.
  • Department of Urology &Transplant Services, Tokyo Women, s Medical University Hospital, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
  • Department of Medicine, RIPAS Hospital, Bandar Seri Begawan BA1710, Brunei Darussalam.

ORCID-Profile: Muhammad Abdul Mabood Khalil, Saeed M G Al-Ghamdi, Ubaidullah Shaik Dawood, Said Sayed Ahmed Khamis, Hideki Ishida, Vui Heng Chong, Jackson Tan

Zitieren

APA

Mabood Khalil, M. A., Al-Ghamdi, S. M. G., Dawood, U. S., Ahmed Khamis, S. S., Ishida, H., Chong, V. H., & Tan, J. (2022). Mammalian Target of Rapamycin Inhibitors and Wound Healing Complications in Kidney Transplantation: Old Myths and New Realities. Journal of Transplantation, 2022, 1-28. https://doi.org/10.1155/2022/6255339

Vancouver

Mabood Khalil MA, Al-Ghamdi SMG, Dawood US, Ahmed Khamis SS, Ishida H, Chong VH, et al. Mammalian Target of Rapamycin Inhibitors and Wound Healing Complications in Kidney Transplantation: Old Myths and New Realities. Journal of Transplantation. 2022;2022:1-28. doi:10.1155/2022/6255339

BibTeX
@article{MaboodKhalil2022,
  author = {Mabood Khalil, Muhammad Abdul and Al-Ghamdi, Saeed M G and Dawood, Ubaidullah Shaik and Ahmed Khamis, Said Sayed and Ishida, Hideki and Chong, Vui Heng and Tan, Jackson},
  title = {Mammalian Target of Rapamycin Inhibitors and Wound Healing Complications in Kidney Transplantation: Old Myths and New Realities},
  journal = {Journal of Transplantation},
  year = {2022},
  volume = {2022},
  pages = {1--28},
  doi = {10.1155/2022/6255339}
}
Kostenlos starten →